1. Immune Design Appoints Lewis W. Coleman to Board of Directors

    Immune Design Appoints Lewis W. Coleman to Board of Directors

    SEATTLE and SOUTH SAN FRANCISCO, Calif. -- Immune Design , a clinical-stage immunotherapy company focused on cancer, today announced the appointment of Lewis W. Coleman to the company's board of directors....

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Lew brings to our Board extensive experience at an operational level and deep knowledge of the financial industry and capital creation. He will be an invaluable resource to help continue the building of Immune Design as a company in the exciting world of cancer immunotherapy.
  3. Topics Mentioned